Forma Therapeutics Holdings Inc (FMTX) Stock: Do Analysts Think You Should Accumulate?

Thursday, October 13, 2022 11:42 AM | InvestorsObserver Analysts

Mentioned in this article

Forma Therapeutics Holdings Inc (FMTX) Stock: Do Analysts Think You Should Accumulate?

InvestorsObserver is giving Forma Therapeutics Holdings Inc (FMTX) an Analyst Rating Rank of 16, meaning FMTX is ranked higher by analysts than 16% of stocks. The average price target for FMTX is $20.75 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating FMTX a Buy today. Find out what this means to you and get the rest of the rankings on FMTX!

See Full FMTX Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Forma Therapeutics Holdings Inc Stock Today?

Forma Therapeutics Holdings Inc (FMTX) stock is trading at $19.99 as of 11:40 AM on Thursday, Oct 13, a gain of $0.01, or 0.05% from the previous closing price of $19.98. The stock has traded between $19.98 and $20.00 so far today. Volume today is low. So far 125,279 shares have traded compared to average volume of 2,674,859 shares. Click Here to get the full Stock Report for Forma Therapeutics Holdings Inc stock.